股市资讯 | 美国反悔!白宫突然宣布将对中国500亿商品征25%关税

wechat omage

美国股市

截至北京时间5月30日凌晨,美股周二大幅收跌,银行板块领跌。意大利重新进行大选的可能性以及中美贸易关系的最新发展令市场承压。

截止收盘,道指跌391.64点,或1.58%,报24361.45点;标普500指数跌31.47点,或1.16%,报2689.86点;纳指跌37.26点,或0.50%,报7396.59点。

受意大利与西班牙等欧洲国家政局的不确定性因素影响,美股周二低开。白宫宣布对500亿美元含有“重要工业技术”的中国进口商品加征25%的关税后,美股跌幅扩大,道指一度下跌超过500点,降至日低24,247.84点。

金融板块大幅下跌,JP摩根大通(105.93, -4.73, -4.27%)(JPM)收跌4.27%,摩根士丹利(49.96, -3.05, -5.75%)(MS)收跌5.8%。银行板块投资者担心全球信贷下滑可能导致国际债券持有者受到连带损失。而且全球政府债券普遍上涨、收益率下降,同样令银行股承压。

贸易战进展:

美国反悔!白宫突然宣布将对中国500亿商品征25%关税

美国白宫官网29日发表声明,美国将加强对获取美国工业重大技术的相关中国个人和实体实施出口管制,并采取具体投资限制,拟于2018年6月30日前正式公布相关措施,之后不久将正式实施。

声明还称,根据《1974年贸易法》第301条,美国将对从中国进口的包括高科技产品在内的总值500亿美元的产品征收25%的关税,其中包括与“中国制造2025”计划相关的产品。最终的进口商品清单将于2018年6月15日之前公布,稍后将对这些进口产品征收关税。

对于中美双边经贸关系,中国商务部发言人高峰曾表示,中方反对美方301调查的单边主义做法。高峰说,在美国已经公布的2000多份书面评论意见中,九成以上反对对中国产品加征关税。这充分说明美方301调查措施不得人心。我们希望美国政府认清民意,终止301调查的有关程序。

高峰还表示,中方愿意从包括美国在内的世界各国扩大进口,也欢迎包括美国企业在内的世界各国企业来中国发展。希望美方取消不应有的贸易限制,提高供给能力,给予中国产品和中国投资公平、公正的待遇,推动两国经济优势互补,实现互利共赢。

   

港股

北京时间5月29日,昨日恒指低开低走,恒指一度跌近0.8%,此后跌幅有所收窄。午后恒指跌幅扩大,临近尾盘,恒指跌幅超1%。截至收盘,恒指跌1%,报30484.58点;国企指数跌1.29%,报11959.08点;红筹指数跌1.22%,报4536.26点。大市成交875.54亿港元

沪港通资金流向方面,沪股通净流入2.8亿,港股通(沪)净流出为5.21亿。

深港通资金流向方面,深股通净流入12.68亿,港股通(深)净流出为2.78亿。

阿里健康:阿里巴巴概念股走高

阿里健康(7.01, 0.24, 3.55%)昨日股价大涨3.55%,报价7.01港元。阿里健康发公告宣布,通过发行股份方式收购阿里巴巴子公司Ali JK Medical Products Limited,总代价相当于106亿港元。总共将发行18.27亿股,每股对价5.8港元。

回顾5月24日收盘,港股阿里影业 (1.06, 0.00, 0.00%) 大涨31.52%,创下自2015年7月以来的最大涨幅。同是阿里系的阿里健康自2月以来也累计上涨了68%,5月24日,阿里健康收盘涨1.47%,不过盘中公司股价一度大涨11.49%。

   

中国A股

北京时间5月29日,昨日三大股指早盘低开,市场指数有所上攻,但在海南板块的拖累下上行力度不足,沪指小幅上涨后再度回落。随后,在白酒、世界杯概念板块延续昨日的强势,医药板块也成为后起之秀,创指翻红呈现震荡格局。临近午盘,受到期货的带动,棉花板块表现活跃,大盘延续了昨日弱势震荡的走势,资金风险偏好下降。午后,市场波澜不惊,三大股指均呈现横盘整理格局。板块个股持续萎靡,市场观望情绪渐浓。尾盘,随着医药板块持续杀跌,带领创业板一路唱衰。虽然助力布局钢铁等权重板块,但对市场起到的积极作用甚微。盘中,独角兽药明康德迎16涨停,市值超越云南白药跻身医药上市公司前三甲。

截止收盘,沪指报3120.46,跌0.47%;深成指报10349.07,跌1.11%;创业板指报1773.65,跌1.29%。

从盘面上看,钢铁、食品安全、宁德时代概念居板块涨幅榜前列,海南、水泥、猪肉居板块跌幅榜前列。

热点板块:

受“钢市供需两旺,钢价上涨矿价震荡 ”等因素影响,钢铁板块大热,方大特钢、包钢股份、永兴特钢、韶钢松山、武进不锈、南钢股份、西宁特钢等个股集体拉升。

受“多重利好显现,客运量增长”等消息影响,机场航运盘中走强,上海机场、深圳机场、白云机场、春秋航空等多股大涨。

来源:东方财富网,新浪财经,同花顺,21世纪经济报道,彭博,华尔街见闻,辉立证券

联系我们开设账户

需要帮助吗?请分享您的详细资料,我们会给您答复。

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com